Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital-Reference-Cited by-同舟云学术

Unlicensed and off-label drug use in paediatrics in a mother-child tertiary care hospital

Published:2016-03 Issue:2 Volume:21 Page:83-87
ISSN:1205-7088
Container-title:Paediatrics & Child Health
language:en
Short-container-title:

Author:

Corny Jennifer,Bailey Benoit,Lebel Denis,Bussières Jean-François

Publisher

Oxford University Press (OUP)

Subject

Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/pch/article-pdf/21/2/83/11125088/pch-21-83.pdf

Reference28 articles.

1. Conference of Professional and Scientific Societies;Shirkey

2. International Conference on Harmonization Clinical Investigation of Medicinal Products in the Pediatric Population E11 (Accessed September 8, 2014).

3. Food and Drug Administration Food and Drug Administration Modernization Act (FDAMA) of 1997 (Accessed September 8, 2014).

4. National Institute of Health Best Pharmaceuticals for Children Act (Accessed September 8, 2014).

5. Food and Drug Administration Pediatric Research Equity Act (Accessed September 8, 2014).

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022;Pharmaceutics;2023-11-21

2. Current situation of pediatric clinical trials in China: focus on trials for drug marketing application and administrative approval;BMC Pediatrics;2022-03-18

3. Supporting patients with unlicensed medicine use: Analysing the script schemas for prescribing, pharmaceutical assessment and supply;Exploratory Research in Clinical and Social Pharmacy;2021-06

4. Assessing a Mass-Based Method for the Preparation of Low-Dosed Paediatric Capsules with Baclofen and Spironolactone;Pharmacy;2021-03-08

5. Survey on Off-Label Use of Antineoplastic Agents in Pediatric Patients using a Large-scale Medical Database in Japan;Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics;2020-11-30